Orthofix International | OFIX - Loan Capital


Orthofix International reported $157.22M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Accuray USD 127.32M 3.53M Sep/2025
AngioDynamics USD 5.9M 5.9M Feb/2025
Artivion USD 214.87M 669K Sep/2025
AtriCure USD 61.86M 0 Dec/2025
Dexcom USD 1.24B 53.6M Dec/2025
EDAP TMS EUR 1.01M 13K Sep/2025
Globus Medical USD 436K 9K Dec/2025
Hologic USD 2.5B 2.1M Dec/2025
Inogen USD 0 0 Jun/2022
Insulet USD 930.8M 4.1M Dec/2025
Integra LifeSciences USD 1.86B 63.76M Dec/2025
J&J USD 39.44B 30M Dec/2025
Medtronic USD 27.62B 1.45B Sep/2025
Mesa Laboratories USD 104.2M 104.3M Sep/2024
Orthofix International USD 157.22M 172K Sep/2025
Plus Therapeutics USD 3.79M 322K Dec/2022
Smith & Nephew USD 3.3B 22M Dec/2025
STAAR Surgical USD 42K 42K Dec/2023
Stryker USD 14.86B 14M Dec/2025
Surmodics USD 29.55M 30K Sep/2024
Tandem Diabetes Care USD 310.04M 446K Dec/2025
Teleflex USD 2.54B 30.06M Dec/2025
Veracyte USD 0 0 Mar/2025
Zimmer Biomet Holdings USD 6.93B 580.6M Dec/2025